EGFR mutation frequency and effectiveness of erlotinib: a prospective observational study in Danish patients with non-small cell lung cancer. [electronic resource]
Producer: 20141001Description: 224-30 p. digitalISSN:- 1872-8332
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- Denmark
- Disease-Free Survival
- ErbB Receptors -- genetics
- Erlotinib Hydrochloride
- Female
- Humans
- Lung Neoplasms -- diagnosis
- Male
- Middle Aged
- Mutation -- genetics
- Predictive Value of Tests
- Prognosis
- Prospective Studies
- Quinazolines -- administration & dosage
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.